↓ Skip to main content

Biopharmaceuticals, an Industrial Perspective

Overview of attention for book
Cover of 'Biopharmaceuticals, an Industrial Perspective'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Biopharmaceuticals, an overview
  3. Altmetric Badge
    Chapter 2 Abciximab: The First Platelet Glycoprotein IIb/IIIa Receptor Antagonist
  4. Altmetric Badge
    Chapter 3 Recombinant Coagulation Factor IX (BeneFIX®)
  5. Altmetric Badge
    Chapter 4 Biopharmaceutical Drug Development: A Case History
  6. Altmetric Badge
    Chapter 5 Follitropin beta (Puregon)
  7. Altmetric Badge
    Chapter 6 Insulin Lispro (Humalog)
  8. Altmetric Badge
    Chapter 7 Interferon beta-1b — the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS)
  9. Altmetric Badge
    Chapter 8 Reteplase, a recombinant plasminogen activator
  10. Altmetric Badge
    Chapter 9 Stabilisation of biopharmaceutical products and finished product formulations
  11. Altmetric Badge
    Chapter 10 Patent Law for Biopharmaceuticals
  12. Altmetric Badge
    Chapter 11 The development of new medicines: an overview
  13. Altmetric Badge
    Chapter 12 The EMEA and regulatory control of (bio)pharmaceuticals within the European Union
  14. Altmetric Badge
    Chapter 13 Biopharmaceutical Validation: an overview
  15. Altmetric Badge
    Chapter 14 Validation of Biopharmaceutical Chromatography Systems
  16. Altmetric Badge
    Chapter 15 Validation of Water for Injections (WFI) for Biopharmaceutical Manufacture
  17. Altmetric Badge
    Chapter 16 Information retrieval and the biopharmaceutical industry: an introductory overview
  18. Altmetric Badge
    Chapter 17 Information technology and the internet as a resource of biopharmaceutical information
  19. Altmetric Badge
    Chapter 18 Marketing Issues for the (Bio)pharmaceutical sector
  20. Altmetric Badge
    Chapter 19 Viral mediated gene therapy
  21. Altmetric Badge
    Chapter 20 Pharmaceutical gene medicines for non-viral gene therapy
Overall attention for this book and its chapters
Altmetric Badge

Mentioned by

wikipedia
1 Wikipedia page

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Biopharmaceuticals, an Industrial Perspective
Published by
Springer Netherlands, March 2013
DOI 10.1007/978-94-017-0926-2
ISBNs
978-9-04-815237-7, 978-9-40-170926-2
Editors

Walsh, Gary, Murphy, Brendan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Iran, Islamic Republic of 1 1%
Spain 1 1%
Hungary 1 1%
Russia 1 1%
Unknown 76 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 18 23%
Researcher 12 15%
Student > Master 10 13%
Student > Bachelor 10 13%
Professor > Associate Professor 4 5%
Other 10 13%
Unknown 16 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 20 25%
Biochemistry, Genetics and Molecular Biology 9 11%
Engineering 6 8%
Medicine and Dentistry 6 8%
Chemistry 5 6%
Other 17 21%
Unknown 17 21%